Cargando…

Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma

SIMPLE SUMMARY: Intrinsic telomere shortening promotes tumorigenesis in cells with impaired DNA damage repair mechanisms, as dysfunctional telomeres lead to chromosomal instability. More recent data show that the telomere length of peripheral blood leukocyte (PBL) cells can be a prognostic marker fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xi, Wezel, Felix, Azoitei, Anca, Meessen, Sabine, Wang, Wenya, Najjar, Gregoire, Wang, Xue, Kraus, Johann M., Kestler, Hans A., John, Axel, Zengerling, Friedemann, Bolenz, Christian, Günes, Cagatay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345040/
https://www.ncbi.nlm.nih.gov/pubmed/34359672
http://dx.doi.org/10.3390/cancers13153774
_version_ 1783734533857738752
author Zheng, Xi
Wezel, Felix
Azoitei, Anca
Meessen, Sabine
Wang, Wenya
Najjar, Gregoire
Wang, Xue
Kraus, Johann M.
Kestler, Hans A.
John, Axel
Zengerling, Friedemann
Bolenz, Christian
Günes, Cagatay
author_facet Zheng, Xi
Wezel, Felix
Azoitei, Anca
Meessen, Sabine
Wang, Wenya
Najjar, Gregoire
Wang, Xue
Kraus, Johann M.
Kestler, Hans A.
John, Axel
Zengerling, Friedemann
Bolenz, Christian
Günes, Cagatay
author_sort Zheng, Xi
collection PubMed
description SIMPLE SUMMARY: Intrinsic telomere shortening promotes tumorigenesis in cells with impaired DNA damage repair mechanisms, as dysfunctional telomeres lead to chromosomal instability. More recent data show that the telomere length of peripheral blood leukocyte (PBL) cells can be a prognostic marker for survival of patients with solid tumors. However, reports on bladder cancer (BC) and renal cell carcinoma (RCC) are not consistent and partly contradictory. Our results show, first, that telomere length is shorter in patients with BC or RCC compared to patients without malignant disease. More importantly, the relative telomere length (RTL) of PBL cells is associated with survival of patients with BC and RCC. Thus, telomere length in PBL cells could be an auxiliary prognostic marker in BC and RCC. ABSTRACT: Background: Telomeres are protein–DNA complexes at the tips of linear chromosomes. They protect the DNA from end-to-end fusion and exonucleolytic degradation. Shortening of telomeric DNA during aging can generate dysfunctional telomeres, promoting tumorigenesis. More recent data indicate that both short and long telomeres of peripheral blood leukocyte (PBL) cells can serve as prognostic biomarkers for cancer risk and may be associated with survival of patients with solid cancers. Telomere length in PBL cells could also be a potential prognostic biomarker for survival in bladder cancer (BC) or renal cell carcinoma (RCC). Methods: The relative telomere length (RTL) of PBL cells was assessed in patients with BC (n = 144) and RCC (n = 144) by using qPCR. A control population of patients without malignant disease (NC, n = 73) was included for comparison. The correlation and association of RTL with histopathological parameters and overall survival (OS) were evaluated. Results: Patients with BC and RCC had significantly shorter telomeres compared to patients without malignant disease. Within the cancer cohorts, multivariate analysis revealed that short RTL is an independent predictor of worse survival in BC (p = 0.039) and RCC (p = 0.041). Conclusion: Patients with BC and RCC had significantly shorter telomeres compared to the normal population. Shorter RTL in BC and RCC was an independent predictor of reduced survival.
format Online
Article
Text
id pubmed-8345040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83450402021-08-07 Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma Zheng, Xi Wezel, Felix Azoitei, Anca Meessen, Sabine Wang, Wenya Najjar, Gregoire Wang, Xue Kraus, Johann M. Kestler, Hans A. John, Axel Zengerling, Friedemann Bolenz, Christian Günes, Cagatay Cancers (Basel) Article SIMPLE SUMMARY: Intrinsic telomere shortening promotes tumorigenesis in cells with impaired DNA damage repair mechanisms, as dysfunctional telomeres lead to chromosomal instability. More recent data show that the telomere length of peripheral blood leukocyte (PBL) cells can be a prognostic marker for survival of patients with solid tumors. However, reports on bladder cancer (BC) and renal cell carcinoma (RCC) are not consistent and partly contradictory. Our results show, first, that telomere length is shorter in patients with BC or RCC compared to patients without malignant disease. More importantly, the relative telomere length (RTL) of PBL cells is associated with survival of patients with BC and RCC. Thus, telomere length in PBL cells could be an auxiliary prognostic marker in BC and RCC. ABSTRACT: Background: Telomeres are protein–DNA complexes at the tips of linear chromosomes. They protect the DNA from end-to-end fusion and exonucleolytic degradation. Shortening of telomeric DNA during aging can generate dysfunctional telomeres, promoting tumorigenesis. More recent data indicate that both short and long telomeres of peripheral blood leukocyte (PBL) cells can serve as prognostic biomarkers for cancer risk and may be associated with survival of patients with solid cancers. Telomere length in PBL cells could also be a potential prognostic biomarker for survival in bladder cancer (BC) or renal cell carcinoma (RCC). Methods: The relative telomere length (RTL) of PBL cells was assessed in patients with BC (n = 144) and RCC (n = 144) by using qPCR. A control population of patients without malignant disease (NC, n = 73) was included for comparison. The correlation and association of RTL with histopathological parameters and overall survival (OS) were evaluated. Results: Patients with BC and RCC had significantly shorter telomeres compared to patients without malignant disease. Within the cancer cohorts, multivariate analysis revealed that short RTL is an independent predictor of worse survival in BC (p = 0.039) and RCC (p = 0.041). Conclusion: Patients with BC and RCC had significantly shorter telomeres compared to the normal population. Shorter RTL in BC and RCC was an independent predictor of reduced survival. MDPI 2021-07-27 /pmc/articles/PMC8345040/ /pubmed/34359672 http://dx.doi.org/10.3390/cancers13153774 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zheng, Xi
Wezel, Felix
Azoitei, Anca
Meessen, Sabine
Wang, Wenya
Najjar, Gregoire
Wang, Xue
Kraus, Johann M.
Kestler, Hans A.
John, Axel
Zengerling, Friedemann
Bolenz, Christian
Günes, Cagatay
Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title_full Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title_fullStr Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title_full_unstemmed Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title_short Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
title_sort shorter leukocyte telomere length is associated with worse survival of patients with bladder cancer and renal cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345040/
https://www.ncbi.nlm.nih.gov/pubmed/34359672
http://dx.doi.org/10.3390/cancers13153774
work_keys_str_mv AT zhengxi shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT wezelfelix shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT azoiteianca shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT meessensabine shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT wangwenya shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT najjargregoire shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT wangxue shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT krausjohannm shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT kestlerhansa shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT johnaxel shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT zengerlingfriedemann shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT bolenzchristian shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma
AT gunescagatay shorterleukocytetelomerelengthisassociatedwithworsesurvivalofpatientswithbladdercancerandrenalcellcarcinoma